Medicap Laboratories · 99-39 · CANADA
For Medicap Laboratories · 99-39 · CANADA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CANADA; product is Edica EZestro Supplement | Edica EZestro Supplement | Edica EZestro Supplement; product code is 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 06/25/2024; address is 3190 Devon Dr , Windsor, Ontario CANADA, verified against its source on 2026-09-16.
- Firm
- Medicap Laboratories verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- CANADA verified
- Address
- 3190 Devon Dr , Windsor, Ontario CANADA verified
- Date published
- 06/25/2024 verified
- Product code
- 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. each item verified
- Product
- Edica EZestro Supplement | Edica EZestro Supplement | Edica EZestro Supplement each item verified
- FDA notes
- The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act. Nutritional information does not comply with 21 CFR Part 101.36. Label fails to declare: Quantitative amount by weight specified for the proprietary blend (EstroG-100) shall be the total weight of all other dietary ingredients contained in the proprietary blend and shall be placed on the same line to the right of the term “Proprietary Blend” or other appropriately descriptive term or fanciful name underneath the column of amounts described in paragraph (b)(2)(ii) of this section (21 CFR 101.36(c)(3)). The other dietary ingredients in descending order of predominance by weight, in a column or linear fashion, and indented under the term “Proprietary Blend” or other appropriately descriptive term or fanciful name (21 CFR 101.36 (c)(2)). The other ingredients list fails to be placed immediately below the Supplement Facts label (21 CFR 101.4(g)). Section 403(y) of the Act. Label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act. Nutritional information does not comply with 21 CFR Part 101.36. Label fails to declare: Quantitative amount by weight specified for the proprietary blend (EstroG-100) shall be the total weight of all other dietary ingredients contained in the proprietary blend and shall be placed on the same line to the right of the term “Proprietary Blend” or other appropriately descriptive term or fanciful name underneath the column of amounts described in paragraph (b)(2)(ii) of this section (21 CFR 101.36(c)(3)). The other dietary ingredients in descending order of predominance by weight, in a column or linear fashion, and indented under the term “Proprietary Blend” or other appropriately descriptive term or fanciful name (21 CFR 101.36 (c)(2)). The other ingredients list fails to be placed immediately below the Supplement Facts label (21 CFR 101.4(g)). Section 403(y) of the Act. Label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act. Nutritional information does not comply with 21 CFR Part 101.36. Label fails to declare: Quantitative amount by weight specified for the proprietary blend (EstroG-100) shall be the total weight of all other dietary ingredients contained in the proprietary blend and shall be placed on the same line to the right of the term “Proprietary Blend” or other appropriately descriptive term or fanciful name underneath the column of amounts described in paragraph (b)(2)(ii) of this section (21 CFR 101.36(c)(3)). The other dietary ingredients in descending order of predominance by weight, in a column or linear fashion, and indented under the term “Proprietary Blend” or other appropriately descriptive term or fanciful name (21 CFR 101.36 (c)(2)). The other ingredients list fails to be placed immediately below the Supplement Facts label (21 CFR 101.4(g)). Section 403(y) of the Act. Label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. each item verified
What the source says
Medicap Laboratories Date Published : 06/25/2024 3190 Devon Dr , Windsor, Ontario CANADA 54 E - - 99 Herbals & Botanical Teas, N.E.C. Date Published: 06/25/2024 Desc: Edica EZestro Supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act. Nutritional information does not comply with 21 CFR Part 101.36. Label fails to declare: Quantitative amount by weight specified for the proprietary blend (EstroG-100) shall be the total weight of all other dietary ingredients contained in the proprietary blend and shall be placed on the same line to the right of the term “Proprietary Blend” or other appropriately descriptive term or fanciful name underneath the column of amounts described in paragraph (b)(2)(ii) of this section (21 CFR 101.36(c)(3)). The other dietary ingredients in descending order of predominance by weight, in a column or linear fashion, and indented under the term “Proprietary Blend” or other appropriately descriptive term or fanciful name (21 CFR 101.36 (c)(2)). The other ingredients list fails to be placed immediately below the Supplement Facts label (21 CFR 101.4(g)). Section 403(y) of the Act. Label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 06/25/2024 Desc: Edica EZestro Supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act. Nutritional information does not comply with 21 CFR Part 101.36. Label fails to declare: Quantitative amount by weight specified for the proprietary blend (EstroG-100) shall be the total weight of all other dietary ingredients contained in the proprietary blend and shall be placed on the same line to the right of the term “Proprietary Blend” or other appropriately descriptive term or fanciful name underneath the column of amounts described in paragraph (b)(2)(ii) of this section (21 CFR 101.36(c)(3)). The other dietary ingredients in descending order of predominance by weight, in a column or linear fashion, and indented under the term “Proprietary Blend” or other appropriately descriptive term or fanciful name (21 CFR 101.36 (c)(2)). The other ingredients list fails to be placed immediately below the Supplement Facts label (21 CFR 101.4(g)). Section 403(y) of the Act. Label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/25/2024 Desc: Edica EZestro Supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act. Nutritional information does not comply with 21 CFR Part 101.36. Label fails to declare: Quantitative amount by weight specified for the proprietary blend (EstroG-100) shall be the total weight of all other dietary ingredients contained in the proprietary blend and shall be placed on the same line to the right of the term “Proprietary Blend” or other appropriately descriptive term or fanciful name underneath the column of amounts described in paragraph (b)(2)(ii) of this section (21 CFR 101.36(c)(3)). The other dietary ingredients in descending order of predominance by weight, in a column or linear fashion, and indented under the term “Proprietary Blend” or other appropriately descriptive term or fanciful name (21 CFR 101.36 (c)(2)). The other ingredients list fails to be placed immediately below the Supplement Facts label (21 CFR 101.4(g)). Section 403(y) of the Act. Label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.